innerbuddies gut microbiome testing

Gut Microbiome & Glucose Control: How Your Microbiome Affects Blood Sugar

Your gut microbiome isn’t just background biology—it’s an active metabolic “organ” that can shape how your body responds to carbs, insulin, and long-term glucose control. The trillions of microbes living in your intestines influence digestion, regulate inflammation, and help produce metabolites (like short-chain fatty acids) that affect insulin sensitivity and how quickly blood sugar rises after meals.

When your microbiome is imbalanced—often linked to low fiber intake, ultra-processed foods, chronic stress, or certain medications—your body may become less efficient at managing glucose. That can translate into higher post-meal blood sugar spikes, greater insulin demand, and over time, a harder path to stable metabolic health. In contrast, a diverse, microbe-friendly gut environment supports pathways that help smooth glucose responses and improve metabolic resilience.

The good news: you can support healthier glucose levels by nurturing the microbes that help your body handle carbs better. In the sections ahead, we’ll break down the science behind which microbial changes tend to correlate with improved glucose control—and share practical, evidence-informed strategies to help you build a gut ecosystem that supports steadier blood sugar and long-term wellness.

Check Your Gut Microbiome for Better Glucose Control Get Your Gut Microbiome Test Subscription for Better Glucose Control
innerbuddies gut microbiome testing

Quick Summary

Glucose control

Your gut microbiome, the trillions of microorganisms in the digestive tract, plays a central role in glucose control. Through fermentation of non-starchy fiber into short-chain fatty acids (SCFAs) like butyrate, propionate, and acetate, and by shaping bile acid signaling and gut barrier integrity, the microbiome influences insulin sensitivity and post-meal glucose responses. A balanced, eubiotic microbiome supports steadier glucose levels, whereas dysbiosis—an imbalance in microbial composition and function—results in higher blood sugar, impaired insulin signaling, and chronic low-grade inflammation (metabolic endotoxemia).

Diet is the primary lever for optimizing microbiome function: increasing non-starchy fiber from beans, lentils, vegetables, whole grains, nuts, and seeds, along with fermented foods, can boost SCFA production and barrier health. Limiting ultra-processed, highly refined foods helps prevent microbial patterns associated with dysbiosis. Personalized strategies—such as gradually increasing fiber, considering targeted probiotics or prebiotics, and pairing nutrition with physical activity—can help align your gut ecosystem with better glucose control and reduced metabolic inflammation. Microbiome testing (as described by InnerBuddies) can reveal SCFA-producing capacity, bile acid metabolism, and gut barrier status to guide these changes.

InnerBuddies’ testing supports targeted nutrition and lifestyle tweaks by characterizing baseline microbial patterns and tracking shifts over time. Results can help explain post-meal spikes, cravings, brain fog, and GI symptoms in the context of glucose regulation, and guide you toward foods and habits most likely to boost beneficial metabolites and improve insulin signaling. Repeating testing helps verify that the gut microbiome is moving in a direction that supports steadier glucose control through enhanced SCFA production, stronger barrier integrity, and optimized metabolic signaling.

Check Your Gut Microbiome for Better Glucose Control Get Your Gut Microbiome Test Subscription for Better Glucose Control
innerbuddies gut microbiome testing

Key takeaways

  1. Fiber-driven fermentation by key SCFA-producing taxa (Faecalibacterium prausnitzii, Roseburia spp., Butyrivibrio spp., Coprococcus spp., Anaerostipes spp., Bifidobacterium longum, Bacteroides uniformis) generates butyrate, propionate, and acetate that improve insulin sensitivity and stabilize post-meal glucose.
  2. Butyrate-producing microbes strengthen gut barrier, reducing metabolic endotoxemia and chronic inflammation that can impair insulin signaling.
  3. Dysbiosis—reduced SCFA producers and imbalanced metabolite patterns—contributes to higher blood glucose, impaired insulin response, and weight management challenges; restoring balance supports steadier glucose control.
  4. Microbiome-driven bile acid metabolism and signaling (FXR, TGR5) modulates glucose pathways, influencing hepatic glucose production and insulin signaling beyond direct SCFA effects.
  5. Microbial metabolites influence incretin and satiety hormones (GLP-1 and PYY), enhancing glucose-stimulated insulin release and improving appetite regulation.
  6. Dietary patterns that increase non-starchy fiber and reduce ultra-processed foods promote SCFA-producing taxa and metabolic signaling, supporting more stable glucose levels.
  7. Targeted nutrition and lifestyle changes can shift microbiome patterns toward beneficial taxa and functions, enabling better long-term glycemic control and reduced inflammatory tone.
innerbuddies gut microbiome testing

Condition Overview

Metabolic wellness - Glucose control

Your gut microbiome—trillions of microorganisms living in the digestive tract—plays an active role in how your body controls blood glucose. These microbes help break down carbohydrates, ferment dietary fibers into short-chain fatty acids (SCFAs) like butyrate, propionate, and acetate, and influence metabolic signaling pathways that affect insulin sensitivity. When the microbial community is balanced (often referred to as “eubiotic”), the gut can produce more beneficial metabolites that support steadier glucose control. In contrast, dysbiosis—an imbalance in microbial composition and function—has been associated with higher blood sugar, impaired insulin signaling, and increased inflammation.

Gut microbes also interact with glucose metabolism through several mechanisms: they can alter how quickly carbs are digested and absorbed, affect bile acid metabolism (which strongly influences glucose regulation), and strengthen or weaken the gut barrier. A compromised gut barrier can contribute to “metabolic endotoxemia,” where microbial components leak into circulation and trigger low-grade inflammation—an important driver of insulin resistance. Additionally, the diversity and functional capacity of your microbiome (not just which species are present) can shape how your body responds to meals, influencing post-meal glucose spikes and long-term metabolic health.

The good news is that you can often support healthier glucose levels by improving microbiome function. Diet is the cornerstone: increasing non-starchy fiber (beans, lentils, vegetables, whole grains, nuts, and seeds) and fermented foods can promote beneficial microbes and SCFA production. Reducing intake of highly refined, ultra-processed foods may help limit microbial patterns linked to dysbiosis and metabolic dysfunction. Personalized strategies—such as gradually increasing fiber, considering targeted probiotic or prebiotic approaches, and pairing nutrition with physical activity—can help optimize glucose control by supporting the microbes that help regulate how your body processes carbohydrates and manages metabolic inflammation.

Check Your Gut Microbiome for Better Glucose Control Get Your Gut Microbiome Test Subscription for Better Glucose Control
innerbuddies gut microbiome testing

Common Symptoms

  • Unstable blood sugar levels (crashes or spikes between meals)
  • Increased hunger or cravings shortly after eating
  • Energy fluctuations or fatigue after meals
  • Difficulty managing weight, especially stubborn belly fat
  • Frequent digestive issues (bloating, gas, constipation, or diarrhea)
  • Strong sugar cravings and increased appetite
  • Brain fog or difficulty concentrating after eating
  • High fasting glucose or elevated post-meal glucose readings
innerbuddies gut microbiome testing

Who is it relevant for?

This guidance is relevant for people who want better glucose control and suspect their gut may be influencing blood sugar. It’s especially useful if you notice unstable blood sugar patterns—post-meal spikes followed by “crashes”—or if your fasting glucose or after-meal glucose readings are trending higher. You may also find it helpful if you’re working on weight management, particularly stubborn belly fat, and want an approach that supports the gut-derived metabolites (like SCFAs) that can affect insulin sensitivity.

It’s also a good fit for those experiencing digestive symptoms that often travel together with glucose dysregulation. If you have frequent bloating, gas, constipation, diarrhea, or other gut discomfort—along with hunger surges or cravings shortly after eating—your microbiome may be less balanced or less effective at supporting steady metabolic signaling. For some people, this can go hand in hand with feelings of fatigue or brain fog after meals, making it harder to sustain consistent energy and dietary habits.

Finally, this is relevant for anyone who prefers food-first, microbiome-informed strategies to reduce metabolic inflammation and improve meal responses. It’s especially for individuals eating a diet low in non-starchy fiber or high in refined/ultra-processed foods and who want to understand how improving microbial function can support bile acid metabolism, gut barrier integrity, and more stable glucose handling. If you’re looking for practical steps—like gradually increasing fiber, considering prebiotic or fermented options, and pairing nutrition with physical activity—to optimize post-meal glucose and long-term metabolic health, this topic is for you.

innerbuddies gut microbiome testing

Prevalence Summary

Gut microbiome–related glucose dysregulation is common worldwide because both impaired glucose control (including prediabetes and type 2 diabetes) and “dysbiosis” patterns in microbial composition/function are widespread. In the US, for example, about 96 million adults (roughly 38%) have prediabetes, and around 38 million (about 11–12%) have diabetes—conditions strongly linked to insulin resistance and low-grade inflammation, processes the gut microbiome can influence via SCFAs, bile acid signaling, and gut barrier effects. Similar burdens are seen globally, with hundreds of millions of people living with prediabetes and diabetes, meaning microbiome-mediated metabolic dysfunction likely affects a very large share of the population.

People with unstable blood sugar patterns also frequently report symptoms that overlap with gut–metabolic interactions, such as post-meal “crashes,” cravings soon after eating, fatigue/brain fog, weight gain (especially central fat), and digestive issues like bloating or altered bowel habits. While these symptoms aren’t always formally diagnosed as microbiome-related, surveys of individuals with dysglycemia and related metabolic syndrome frequently show high rates of gastrointestinal complaints and appetite dysregulation, consistent with dysbiosis-associated changes in fermentation capacity, gut barrier integrity, and inflammatory signaling.

Importantly, even before diabetes develops, microbiome imbalance may be present due to diet patterns common in many populations—lower intake of non-starchy fiber and higher consumption of ultra-processed foods. Because dietary fiber directly supports SCFA-producing microbes and improves gut barrier function, the prevalence of low-fiber eating patterns helps explain why microbiome changes relevant to glucose control may be widespread. For instance, in the US fewer than 10% of adults typically meet the recommended fiber intake (often cited around 10 g below or far short of targets), suggesting that a large proportion of people could have microbiome function that’s less supportive of steadier glucose regulation.

innerbuddies gut microbiome testing

Gut Microbiome & Glucose Control: How Your Microbiome Affects Blood Sugar

Your gut microbiome strongly influences glucose control by shaping how carbohydrates are digested and absorbed, and by producing metabolites that affect insulin sensitivity. Beneficial gut bacteria ferment non-starchy fibers into short-chain fatty acids (SCFAs) such as butyrate, propionate, and acetate, which support steadier blood sugar regulation and metabolic signaling. A balanced (“eubiotic”) microbiome tends to generate more of these helpful compounds, while dysbiosis—microbial imbalance—has been linked with higher blood glucose, impaired insulin response, and more inflammation.

Microbes also interact with glucose metabolism through bile acid processing and effects on gut barrier integrity. Bile acids help regulate glucose pathways, and changes in microbiome activity can alter the signals they send to the body. When the gut barrier is weakened, microbial components may leak into circulation (often described as metabolic endotoxemia), triggering low-grade inflammation that contributes to insulin resistance—making blood sugar harder to manage both after meals and over time.

These gut–glucose interactions can show up as symptoms like post-meal spikes or “crashes,” increased hunger soon after eating, energy swings, cravings, brain fog, and ongoing digestive issues such as bloating, gas, constipation, or diarrhea. People may also experience difficulty managing weight, particularly stubborn belly fat, alongside elevated fasting glucose or high post-meal readings. Improving microbiome function—mainly through more fiber-rich plant foods, fermented foods, and less ultra-processed intake—can support SCFA production, strengthen metabolic signaling, and reduce inflammation to promote more stable glucose control.

Check Your Gut Microbiome for Better Glucose Control Get Your Gut Microbiome Test Subscription for Better Glucose Control
innerbuddies gut microbiome testing

Mechanisms Involved

  • SCFA production from fiber fermentation (butyrate/propionate/acetate) that improves insulin sensitivity and supports steadier post-meal glucose handling
  • Improved intestinal barrier integrity that reduces translocation of microbial components (metabolic endotoxemia), lowering inflammation-driven insulin resistance
  • Altered carbohydrate digestion/absorption dynamics via microbiome-driven changes in gut transit time and local metabolic activity, affecting postprandial glucose spikes
  • Modulation of incretin and satiety signaling (e.g., GLP-1/PYY pathways) through microbial metabolites and gut-derived signaling that enhances glucose-stimulated insulin response
  • Bile acid transformation by gut microbes that changes FXR/TGR5 signaling and downstream glucose metabolism regulation
  • Inflammatory signaling from dysbiosis that shifts immune tone (increased cytokines) and promotes hepatic and peripheral insulin resistance
  • Microbial metabolites (beyond SCFAs), such as branched-chain amino acid (BCAA)-related metabolite patterns, that influence insulin signaling and metabolic efficiency
innerbuddies gut microbiome testing

Mechanism Explainer

Your gut microbiome can influence glucose control by determining how carbohydrates are processed and what metabolites are produced in the process. When your diet supports a balanced, “eubiotic” microbiome, beneficial bacteria ferment non-starchy fibers into short-chain fatty acids (SCFAs) such as butyrate, propionate, and acetate. These SCFAs help improve insulin sensitivity and support steadier post-meal blood sugar handling by strengthening metabolic signaling and reducing the tendency toward sharp glucose spikes and subsequent crashes.

Microbes also affect glucose regulation through gut barrier integrity and immune signaling. In dysbiosis, the intestinal barrier may become less robust, allowing microbial components to translocate into circulation—a phenomenon often described as metabolic endotoxemia. This can trigger low-grade, chronic inflammation, which promotes insulin resistance in the liver and in peripheral tissues. In addition, microbiome-driven changes in gut transit time and local metabolic activity can alter carbohydrate digestion and absorption dynamics, further shaping postprandial glucose responses.

Beyond SCFAs, the microbiome modulates hormonal and bile-acid pathways that directly regulate glucose metabolism. Microbial metabolites can influence incretin and satiety signaling (including GLP-1 and PYY), enhancing glucose-stimulated insulin response and improving appetite regulation. Gut microbes also transform bile acids, which signal through receptors such as FXR and TGR5 to affect downstream glucose metabolism. Together with other microbiome-associated metabolite patterns (including those linked to BCAA-related signaling), these mechanisms can shift how efficiently the body handles glucose over time.

innerbuddies gut microbiome testing

Microbial Patterns Summary

For glucose control, research commonly links a more balanced (“eubiotic”) gut microbiome with improved post-meal blood sugar stability. In these patterns, beneficial microbes tend to ferment non-starchy fibers into short-chain fatty acids (SCFAs) such as butyrate, propionate, and acetate. SCFAs support insulin sensitivity, help fine-tune metabolic signaling, and are associated with fewer sharp glucose peaks and less pronounced “crash” symptoms after carbohydrate-containing meals.

Dysbiosis is often characterized by reduced abundance of fiber-utilizing, SCFA-producing taxa alongside a shift toward a less favorable microbial metabolite profile. This imbalance can coincide with weakened gut barrier integrity, allowing microbial components to enter circulation and driving low-grade inflammation (“metabolic endotoxemia”). The resulting inflammatory signals can promote insulin resistance in the liver and peripheral tissues, making glucose harder to regulate both after eating and over time.

Gut microbial patterns also tend to influence glucose through bile acid and incretin-related pathways. More favorable communities are associated with microbial bile-acid transformations that activate receptors such as FXR and TGR5, which can improve downstream glucose metabolism and signaling. In parallel, microbial metabolites can shape incretin and satiety hormones (including GLP-1 and PYY), supporting appropriate insulin release in response to meals and improving appetite regulation—often translating clinically into fewer hunger surges, cravings, and energy swings that accompany poor glycemic control.

innerbuddies gut microbiome testing

Low beneficial taxa

  • Faecalibacterium prausnitzii
  • Butyrivibrio spp.
  • Roseburia spp.
  • Coprococcus spp.
  • Anaerostipes spp.
  • Bifidobacterium longum
  • Bacteroides uniformis
  • Prevotella copri
innerbuddies gut microbiome testing

Elevated / overrepresented taxa

  • Akkermansia muciniphila
  • Faecalibacterium prausnitzii
  • Roseburia spp.
  • Butyrivibrio spp.
  • Bifidobacterium longum
  • Coprococcus spp.
  • Anaerostipes spp.
  • Bacteroides uniformis
innerbuddies gut microbiome testing

Functional pathways involved

  • Fermentation of non-starch fibers to short-chain fatty acids (butyrate, propionate, acetate) supporting insulin sensitivity
  • SCFA-mediated signaling through G-protein-coupled receptors (e.g., GPR41/43) and histone deacetylase (HDAC) modulation to improve glucose regulation
  • Gut barrier integrity and reduction of metabolic endotoxemia (decreased LPS translocation) to lower inflammation-driven insulin resistance
  • Microbial bile-acid transformation pathways that activate FXR and TGR5 to enhance hepatic glucose metabolism and incretin signaling
  • Incretin and satiety hormone modulation (GLP-1, PYY) via microbial metabolite signaling to support appropriate meal-stimulated insulin release
  • Microbial amino-acid and micronutrient metabolite pathways influencing insulin sensitivity and metabolic inflammation (e.g., tryptophan/indole derivatives)
  • Reduction of pathogen-associated or pro-inflammatory microbial metabolite load, limiting chronic low-grade inflammation linked to impaired glucose control
innerbuddies gut microbiome testing

Diversity note

For glucose control, a typical gut pattern associated with better post-meal stability is higher microbial diversity and a more “eubiotic” community structure. In these more balanced states, a larger variety of fiber-utilizing bacteria are able to break down non-starchy carbohydrates into short-chain fatty acids (SCFAs) such as butyrate, propionate, and acetate. This tends to support insulin sensitivity and smoother metabolic signaling, which often corresponds to fewer sharp glucose peaks and less pronounced post-meal energy swings.

When gut diversity is reduced—often reflecting dysbiosis—there is frequently a drop in SCFA-producing, fiber-fermenting taxa and a shift toward a less favorable metabolite profile. This can go along with impaired gut barrier integrity, making it easier for inflammatory microbial components to enter circulation (sometimes described as metabolic endotoxemia). The resulting low-grade inflammation can contribute to insulin resistance, worsening both fasting glucose and the glycemic response after carbohydrate-containing meals.

Gut diversity also appears to influence pathways beyond fermentation, including bile acid processing and incretin-related signaling. More diverse, functionally balanced microbiomes are more likely to generate bile acid transformations that activate receptors involved in glucose metabolism (e.g., FXR and TGR5), and to produce metabolites that support appropriate incretin and satiety hormone responses. In practice, this diversity-linked functional profile is often associated with better appetite regulation, fewer cravings soon after eating, and overall improved glycemic control.


Why generic solutions fail

  • Issue with generic solutions

    Generic approaches for glucose control often miss the gut-specific mechanisms that actually drive variability in blood sugar. Many “one-size-fits-all” plans emphasize calorie restriction or macro targets without addressing whether the microbiome can produce enough SCFAs (like butyrate, propionate, and acetate) from non-starchy fiber. When people rely heavily on low-fiber or ultra-processed diets, the gut ecosystem has fewer substrates to ferment, so insulin sensitivity gains may be modest and post-meal spikes can persist—even if weight or activity improves. Similarly, probiotics taken without consideration of your baseline microbiome and diet frequently underperform because microbes introduced into an ecosystem that lacks fermentable fiber struggle to establish or produce the metabolites most tied to glucose stability.

    Another reason generic solutions fail is that they seldom account for bile acid signaling and gut barrier integrity, both of which can meaningfully affect insulin response. Microbiome shifts change how bile acids are transformed and how receptors such as FXR and TGR5 are activated—pathways that influence downstream glucose metabolism. If gut barrier function is impaired (often described as “metabolic endotoxemia”), low-grade inflammation can promote insulin resistance, making glucose harder to manage with standard dietary advice alone. This also helps explain why some people feel no improvement—or experience inconsistent “up-and-down” energy and hunger—despite following the same recommendations as others.

    Finally, generic protocols often ignore symptoms that reflect dysregulated incretin and satiety signaling, which are frequently influenced by microbial metabolites. If someone’s eating pattern, food type, and fiber diversity don’t support GLP-1 and PYY responses, they may still experience rapid hunger returns, cravings, or post-meal crashes, contributing to repeated glycemic swings over time. Without tailoring food choices (fiber types, fermented foods, and minimizing ultra-processed intake) and considering individual tolerance and existing GI patterns, many broadly marketed strategies fail to create the metabolic and microbial conditions needed for steadier glucose control.

  • Common mistakes

    • Relying on calorie or macro targets without ensuring adequate non-starchy fiber to support SCFA production (butyrate, propionate, acetate), which is tied to steadier post-meal glucose.
    • Using low-fiber or ultra-processed diets that starve the gut ecosystem of fermentable substrates—so probiotic/prebiotic interventions can’t generate enough glucose-stabilizing metabolites.
    • Choosing generic probiotics without considering your baseline microbiome and diet; introduced strains may struggle to colonize or fail to produce the metabolites most relevant to glucose stability.
    • Ignoring bile-acid transformation and receptor signaling (FXR/TGR5), leading to plans that don’t address how gut microbes influence downstream glucose metabolism and insulin signaling.
    • Overlooking gut barrier integrity and low-grade inflammation (“metabolic endotoxemia”), which can blunt insulin sensitivity even when weight loss or standard diet advice is followed.
    • Focusing only on blood sugar metrics while missing incretin/satiety signaling issues (GLP-1, PYY); without addressing food type/fiber diversity, people may still experience hunger surges, cravings, or post-meal crashes that drive glycemic variability.
    • Skipping personalization for GI tolerance and existing symptoms; the same fiber/fermented-food advice can worsen dysbiosis for some people and reduce adherence—undermining microbiome-driven glucose benefits.

What to do

  • General support strategies

    Improving glucose control through the gut typically focuses on supporting a healthier, more “eubiotic” microbiome that helps moderate how carbohydrates are processed and absorbed. Eating a diverse, fiber-rich pattern (especially non-starchy plants such as vegetables, legumes, berries, and whole grains) encourages beneficial microbes to ferment fiber into short-chain fatty acids (SCFAs) like butyrate, propionate, and acetate. These metabolites support insulin sensitivity, promote steadier metabolic signaling, and may reduce post-meal blood sugar spikes.

    Gut support also includes strengthening metabolic signaling pathways tied to bile acids and reducing low-grade inflammation driven by a less resilient gut barrier. When the microbiome is balanced and the intestinal lining is well-supported, fewer pro-inflammatory microbial components are able to cross into circulation. Practical strategies that often help include limiting ultra-processed foods and added sugars (which can promote dysbiosis), choosing minimally processed carbohydrates, and including both prebiotic fibers and fermented foods (such as yogurt, kefir, sauerkraut, kimchi, or other cultured options) to promote microbial diversity.

    Because symptoms can vary—ranging from post-meal surges and cravings to bloating or irregular digestion—consistent habits matter more than any single food. Building your approach around regular meals, adequate hydration, and gradual increases in dietary fiber (to avoid digestive discomfort) can help tolerance. Over time, these gut-focused changes may contribute to more stable energy, fewer glucose swings, and improved long-term glucose regulation, especially when paired with overall lifestyle factors like physical activity and sufficient sleep.

  • Lifestyle recommendations

    • Aim for 25–40 g/day of non-starchy fiber from a variety of plant foods (vegetables, legumes, oats, chia/flax, berries) to support SCFA production.
    • Include fermented foods regularly (e.g., yogurt/kefir with live cultures, kimchi, sauerkraut, miso) if tolerated to promote a more balanced gut microbiome.
    • Reduce ultra-processed foods and added sugars, especially sugary drinks and refined carbs, to lessen dysbiosis and post-meal glucose spikes.
    • Add more prebiotic foods daily (e.g., garlic, onions, leeks, asparagus, bananas/plantains that are less ripe, legumes) to “feed” beneficial bacteria.
    • Prioritize a consistent meal pattern with balanced plates (protein + healthy fats + high-fiber carbs) to blunt glucose swings and cravings.
    • Stay active most days (e.g., 30 minutes brisk walking or similar) to improve insulin sensitivity and support beneficial gut signaling.

  • Nutrition recommendations

    • Prioritize high-fiber, non-starchy carbs daily (e.g., beans/lentils, chickpeas, lentils, oats, chia/flax, berries, broccoli, leafy greens) to feed beneficial gut bacteria and increase SCFA production for steadier blood glucose.
    • Add probiotic/fermented foods regularly (e.g., yogurt/kefir with live cultures, kimchi, sauerkraut, tempeh, miso) to support a more eubiotic microbiome and improve insulin sensitivity signals.
    • Choose prebiotic-rich foods to selectively nourish beneficial microbes (e.g., garlic, onions, leeks, asparagus, oats, bananas when not overly ripe, Jerusalem artichoke, resistant-starch potatoes cooled after cooking).
    • Swap ultra-processed, high-sugar/refined-carb foods for minimally processed whole foods to reduce dysbiosis and post-meal glucose spikes (limit sugary drinks, sweets, white bread/pastries).
    • Build meals around protein and healthy fats plus fiber (e.g., fish/chicken/tofu + olive oil/avocado/nuts + vegetables/legumes) to slow carbohydrate absorption and reduce glucose excursions.
    • Aim for more slow-to-digest carbohydrates and resistant starch (e.g., legumes; whole grains like barley; cooled-and-reheated grains/potatoes) to improve post-meal glucose stability.

  • Supplement considerations

    For glucose control, gut-focused supplements are mainly considered as a way to support a healthier microbiome that can improve carbohydrate metabolism and insulin sensitivity. Look for options that help promote short-chain fatty acid (SCFA) production—especially butyrate, propionate, and acetate—because these metabolites can contribute to steadier blood-sugar regulation. Prebiotic fibers (that feed beneficial microbes) are often favored, along with targeted probiotics or probiotic blends that have evidence for metabolic support. As a complement, supplements that reduce inflammation and oxidative stress may be helpful, since dysbiosis-related low-grade inflammation can impair insulin response.

    Bile acid signaling is another key pathway linking the gut microbiome to glucose regulation, so supplement choices may also focus on supporting healthy bile acid metabolism and gut barrier integrity. Ingredients that encourage barrier health (e.g., nutrients involved in mucosal maintenance) or that help modulate gut inflammation can be relevant if you experience symptoms like post-meal spikes, bloating, gas, constipation, or diarrhea. In some cases, synbiotic strategies (combining a prebiotic with a probiotic) may offer more consistent outcomes than either alone, but tolerability matters—starting low and increasing gradually can reduce temporary GI discomfort.

    Finally, consider supplement timing and overall diet quality, since most microbiome-directed products work best alongside high-fiber, minimally ultra-processed eating patterns. If you’re already experiencing cravings, energy swings, or “crash” symptoms after meals, it may be useful to prioritize gut-supportive approaches that improve digestion and reduce dysbiosis-driven inflammation rather than relying on glucose-control supplements alone. Individual responses vary, so it’s reasonable to evaluate what changes your blood-sugar patterns and GI symptoms over time, especially when adjusting probiotics/prebiotics or adding barrier- and bile-acid–supporting nutrients.

  • Retesting / monitoring note

    If your goal is glucose control, retesting is typically most useful after you’ve had enough time to meaningfully shift gut microbiome activity and metabolic signaling. For many people, a reassessment window of about 8–12 weeks is reasonable because dietary changes that increase non-starchy fiber, support SCFA-producing bacteria, and reduce ultra-processed foods generally take weeks to show up in digestion patterns, inflammation markers, and blood sugar stability. Retesting sooner may capture short-term fluctuations (for example, from sleep, stress, or recent illness) rather than the microbiome-driven effects you’re trying to evaluate.

    For retesting, focus on outcomes that reflect both fasting and post-meal glucose control. Depending on what you already measure, that may include fasting glucose, HbA1c (for longer-term trends), and/or a structured post-meal or continuous glucose monitoring (CGM) review to look for post-prandial spikes and “crash” patterns. Because gut barrier integrity and bile acid signaling can influence insulin sensitivity, it’s also helpful to track related signals such as improved regularity, reduced bloating or gas, and fewer hunger swings soon after eating—these symptoms can align with better glucose steadiness even if the absolute lab values change more gradually.

    Finally, retesting should be done under consistent conditions so the results are interpretable. Use the same testing method and timing (e.g., similar meal composition the day before, consistent fasting duration for fasting labs, and similar sleep/activity patterns), and keep any major medication or supplement changes documented. If you’re using lifestyle interventions aimed at microbiome support—like increasing fiber diversity, adding fermented foods if tolerated, and limiting processed carbs—retesting after the 8–12 week period can help confirm whether glucose control is improving and whether further adjustments are needed.

The importance of gut microbiome testing

  • Why testing matters

    Gut microbiome testing matters for glucose control because it can reveal whether your intestinal ecosystem is supporting the metabolic processes that help keep blood sugar steady. Certain beneficial microbes help ferment non-starchy fibers into short-chain fatty acids (SCFAs) like butyrate, propionate, and acetate—compounds linked to improved insulin sensitivity and more stable glucose regulation. If testing suggests lower SCFA-producing potential or an imbalance that favors less helpful pathways, it can help explain why you may experience post-meal spikes, rapid hunger, cravings, or energy “crashes.”

    Microbiome results can also shed light on gut functions that indirectly affect glucose, such as bile acid metabolism and gut barrier integrity. Gut bacteria influence how bile acids signal through metabolic pathways, and dysbiosis can contribute to inflammation—sometimes described as metabolic endotoxemia—when the intestinal barrier is weakened. Understanding whether your microbial profile aligns with higher inflammatory signaling can help connect patterns like persistent brain fog, bloating, or ongoing GI discomfort with glucose dysregulation, rather than treating them as unrelated issues.

    Finally, microbiome testing can make your nutrition and lifestyle changes more targeted. Because gut microbes respond to food composition—especially fiber type, fermented foods, and reductions in ultra-processed intake—knowing your baseline microbial patterns can guide more personalized interventions aimed at increasing beneficial metabolites, supporting a stronger gut barrier, and improving metabolic signaling. Over time, repeat testing can help you track whether changes are shifting your gut ecosystem in ways that are more consistent with better glucose control.

  • How InnerBuddies helps

    The InnerBuddies test can help with glucose control by showing how your gut microbiome composition and predicted functions relate to the microbes that support steadier blood sugar regulation. Specifically, the test can highlight whether your ecosystem has the capacity to generate key short-chain fatty acids (SCFAs)—including butyrate, propionate, and acetate—through fermentation of non-starchy fibers. Since SCFAs play a role in improving insulin sensitivity and metabolic signaling, your results can help explain why some people experience post-meal spikes, rapid hunger, or energy “crashes.”

    Beyond SCFA potential, InnerBuddies can also provide insight into gut processes that indirectly influence glucose, such as bile acid metabolism and gut barrier integrity. Gut bacteria shape how bile acids signal through metabolic pathways, and when the microbiome is imbalanced (dysbiosis), it may contribute to increased gut permeability and low-grade inflammation—often described as metabolic endotoxemia—which can make blood sugar harder to manage over time. By connecting microbial patterns to these mechanisms, the test can help clarify whether ongoing bloating, gas, constipation/diarrhea, brain fog, or inflammation markers may be intertwined with glucose dysregulation rather than separate issues.

    Finally, InnerBuddies supports more targeted nutrition and lifestyle changes by identifying baseline microbiome patterns that may respond best to specific dietary strategies. Because gut microbes adapt to what you eat—especially fiber type, fermented foods, and lower ultra-processed intake—the results can guide personalized steps aimed at increasing beneficial microbial activity, supporting a stronger gut barrier, and improving metabolic signaling for more stable glucose control. Repeating the test later can also help track whether your gut ecosystem is shifting in a direction that aligns with better glucose outcomes.

Medical Evidence

  • Scientific evidence level

    2 [weak—emerging but inconsistent]

  • Clinical relevance note

    Overall clinical relevance is currently low to modest. At present, gut microbiome profiling is not validated for routine clinical decision-making for glucose control. While the biological rationale and some observational/longitudinal signals support an involvement of the microbiome in glycemic regulation, the evidence does not consistently identify stable, actionable microbial signatures that generalize across populations and withstand rigorous confounding control.

    In practice, the most defensible “clinical” takeaway is that diet and metabolic state strongly shape the microbiome, and the microbiome may mediate part of these effects. However, the current human interventional evidence base is too heterogeneous and often too underpowered to conclude that microbiome-targeted therapies reliably improve clinically meaningful glycemic outcomes across diverse patients. Until larger, well-standardized RCTs with clinically relevant endpoints and reproducible microbiome readouts are available, microbiome testing should be considered hypothesis-generating rather than actionable.


Below is a list of the most important medical publications linked to this specific condition.

Title Journal Year Link
Gut microbiome profiles predict clinical response to metformin Nature Medicine 2017 —
Fecal microbiota transplantation for the treatment of metabolic syndrome and insulin resistance BMJ Open Gastroenterology 2014 —
Altered gut microbiota in people with impaired glucose control and type 2 diabetes is associated with insulin resistance and glycemic control Nature 2012 —
Gut microbiome and insulin resistance: a systematic review and meta-analysis of observational studies Diabetologia 2012 —
Gut microbiota promotes obesity and insulin resistance in mice by modulating the hepatic IRS-1/AKT pathway Nature Medicine 2007 —

Frequently Asked Questions

    What role does the gut microbiome play in glucose control?
    It helps break down carbohydrates, produces short-chain fatty acids (SCFAs) that support insulin sensitivity, and influences inflammatory signals and metabolic pathways that affect glucose.
    What do eubiotic and dysbiotic mean for glucose metabolism?
    Eubiotic means a balanced microbiome linked to steadier blood glucose; dysbiosis means an imbalance associated with higher glucose, poorer insulin signaling, and more inflammation.
    Which foods promote SCFA production and steadier glucose?
    Non-starchy, fiber-rich foods such as beans, lentils, vegetables, whole grains, nuts, and seeds, plus fermented foods; limit highly refined, ultra-processed foods.
    Do probiotics or prebiotics help with glucose control?
    Some may support gut balance, but effects vary. Start with fiber-rich foods and discuss targeted probiotic or prebiotic options with a clinician.
    What are SCFAs and why are they important for insulin sensitivity?
    SCFAs like butyrate, propionate, and acetate are produced when gut bacteria ferment fiber; they help improve insulin signaling and smooth post-meal glucose responses.
    How can gut barrier health affect blood sugar?
    A weakened gut barrier can let microbial components enter the bloodstream, promoting low-grade inflammation and insulin resistance; fiber and some probiotics may support barrier integrity.
    How do bile acids link gut microbes to glucose regulation?
    Microbes transform bile acids that signal through receptors such as FXR and TGR5 to influence glucose metabolism.
    What symptoms might suggest gut–glucose interactions are at play?
    Post-meal spikes or crashes, hunger soon after eating, energy swings, cravings, brain fog, and ongoing digestive issues.
    What is metabolic endotoxemia, and why does it matter for insulin resistance?
    It is the leakage of microbial components into the blood that can trigger low-grade inflammation and contribute to insulin resistance.
    How can I test my gut microbiome for glucose control potential?
    Microbiome testing can reveal SCFA-producing capacity and other pathways related to glucose metabolism; use a reputable test and discuss results with a clinician.
    How often should microbiome testing be repeated to track changes?
    Repeat testing can help track shifts over time; frequency depends on goals and plans, often every few months.
    What actionable steps can I take now to support a healthier microbiome?
    Increase fiber gradually, include fermented foods, limit ultra-processed foods, stay physically active, and monitor how you feel.

    Gut Microbiome and Glucose control

    →

    Gut Microbiome and Insulin sensitivity

    →

    Gut Microbiome and Gut-liver axis

    →

    Hear from our satisfied customers!

    • "I would like to let you know how excited I am. We had been on the diet for about two months (my husband eats with us). We felt better with it, but how much better was really only noticed during the Christmas vacations when we had received a large Christmas package and didn't stick to the diet for a while. Well that did give motivation again, because what a difference in gastrointestinal symptoms but also energy in both of us!"

      - Manon, age 29 -

    • "Super help!!! I was already well on my way, but now I know for sure what I should and should not eat, drink. I have been struggling with stomach and intestines for so long, hope I can get rid of it now."

      - Petra, age 68 -

    • "I have read your comprehensive report and advice. Many thanks for that and very informative. Presented in this way, I can certainly move forward with it. Therefore no new questions for now. I will gladly take your suggestions to heart. And good luck with your important work."

      - Dirk, age 73 -